Results 81 to 90 of about 6,540 (205)

The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons [PDF]

, 1975
It has been reported that hyperlipidemia can be alleviated in human beings with an end to side portacaval shunt. Understanding the mechanism of the effect has important implications, including the possibility of devising other ways of lowering serum ...
Lee, IY, Porter, KA, Putnam, CW, Starzl, TE   +3 more
core  

Ожирение снижает адаптационные возможности беременных женщин [PDF]

, 2015
ОЖИРЕНИЕЖЕНЩИНЫ БЕРЕМЕННЫЕИНСУЛИНОРЕЗИСТЕНТНОСТЬГИПЕРТРИГЛИЦЕРИДЕМИЯакушерские осложненияАДАПТАЦИИ ПСИХОСОЦИАЛЬНОЙ ...
Тарасенко, К. В.
core  

Portal Diversion: Treatment for Glycogen Storage Disease and Hyperlipemia [PDF]

, 1975
Putnam, CW, Starzl, TE
core   +1 more source

Retardation of atherosclerosis in immunocompetent apolipoprotein (apo) E-deficient mice followingliver-directed administration of a [E1-, E3-,polymerase-] adenovirus vector containing the elongation factor-1a promoter driving expression of human apoE cDNA [PDF]

, 2005
Although gene transfer of human apolipoprotein E (apoE), a 34-kDa circulating glycoprotein, to the liver of apoEdeficient(apoE-/-) mice using recombinant adenoviral vectors (rAd) is antiatherogenic, its full therapeutic potentialhas yet to be realized ...
Amalfitano, A, Dickson, G, Graham, IR, Harris, JD, Owen, JS, Schepelmann, S, Stannard, AK   +6 more
core  

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia

Arquivos Brasileiros de Cardiologia
Maria Cristina de Oliveira Izar, Francisco Antonio Helfenstein Fonseca   +1 more
doaj   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 4 [PDF]

, 1977

core   +1 more source

Portal diversion for inborn errors of metabolism: With special reference to glycogen storage disease, Type II hyperlipidemia, and juvenile Gaucher's disease [PDF]

, 1978
Putnam, CW, Starzl, TE
core  

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial. [PDF]

J Am Heart Assoc
Geba GP, Mohammadi KA, Damask A, Paulding C, Lotta LA, Hindy G, Pordy R, Manvelian G, Shapiro MD, Bittner VA, Bhatt DL, Szarek M, Schwartz GG, Steg PG, Fazio S.   +14 more
europepmc   +1 more source

Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate. [PDF]

Endocrinol Diabetes Metab Case Rep
Miyauchi S, Utsunomiya Y, Okamoto M, Akesaka K, Ono K, Hara Y, Miyazaki M, Nakaguchi H, Miyake T, Furukawa S, Ebisui O, Hiasa Y, Matsuura B.   +12 more
europepmc   +1 more source

Case Report: Clinical and genetic analysis of a family with hereditary spherocytosis combined with familial chylomicronemia syndrome. [PDF]

Front Genet
Qin Y, Liu Y, Li K, Deng Y, Li H, Chen X, Pan X, Huang X, Xie M, Long X, Tang S.   +10 more
europepmc   +1 more source